Dirk Erdmann
Impact in
- Cell Biology top 5%
- Hippo pathway signaling and YAP/TAZ
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Cell Biology 12
- Hippo pathway signaling and YAP/TAZ 12
- Genetics 5
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Co-authors
- Patrizia Fontana (18 shared papers)Catherine Zimmermann (19 shared papers)Patrick Chêne (19 shared papers)Yannick Mesrouze (13 shared papers)Pascal Furet (6 shared papers)Tobias Schmelzle (8 shared papers)Jutta Heim (2 shared papers)Marco Meyerhofer (12 shared papers)
- Journals
- Protein Science (6 papers)Molecular Cancer Therapeutics (3 papers)ChemBioChem (2 papers)Blood (1 paper)RSC Chemical Biology (1 paper)
- Partner nations
- SwitzerlandUnited StatesSweden
In The Last Decade
Dirk Erdmann
31 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 74
- Cell Biology 307
- Genetics 108
- Molecular Biology 676
- Oncology 121
- Cancer Research 65
Countries citing papers authored by Dirk Erdmann
This map shows the geographic impact of Dirk Erdmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Erdmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Erdmann more than expected).
Fields of papers citing papers by Dirk Erdmann
This network shows the impact of papers produced by Dirk Erdmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Erdmann. The network helps show where Dirk Erdmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Erdmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 411 | |
| 2 | 1996 | 196 | |
| 3 | 2012 | 138 | |
| 4 | 2010 | 104 | |
| 5 | 2000 | 86 | |
| 6 | 2013 | 67 | |
| 7 | 2017 | 59 | |
| 8 | 2017 | 55 | |
| 9 | 1995 | 47 | |
| 10 | 2021 | 42 | |
| 11 | 2005 | 33 | |
| 12 | 2019 | 31 | |
| 13 | 2018 | 30 | |
| 14 | 2014 | 28 | |
| 15 | 2019 | 26 | |
| 16 | 2010 | 22 | |
| 17 | 2000 | 21 | |
| 18 | 2008 | 20 | |
| 19 | 2024 | 20 | |
| 20 | 2020 | 18 |
About Dirk Erdmann
Dirk Erdmann is a scholar working on Cell Biology, Genetics, Molecular Biology, Oncology and Computational Theory and Mathematics, having authored 32 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Protein Tyrosine Phosphatases (3 papers), Protein Structure and Dynamics (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Cell Biology (307 citations), Genetics (108 citations), Molecular Biology (676 citations), Oncology (121 citations) and Cancer Research (65 citations). Dirk Erdmann has collaborated with scholars based in Switzerland, United States and Sweden. Frequent co-authors include Patrizia Fontana, Catherine Zimmermann, Patrick Chêne, Yannick Mesrouze, Pascal Furet, Tobias Schmelzle, Jutta Heim, Marco Meyerhofer, Fedir M. Bokhovchuk and Joseph Rahuel. Their work appears in journals such as Protein Science, Molecular Cancer Therapeutics, ChemBioChem, Blood and RSC Chemical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.